Xiawei Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Xiawei Cheng has a total of 142 co-authors. Here are the top co-authors by number of shared publications:
- Qiming Sun
Center for Metabolism Research, The Fourth Affiliated Hospital of Zhejiang University School of Medicine and International School of Medicine, International Institutes of Medicine, Zhejiang University 1 Department of Respiratory and Critical Care Medicine Yiwu
5 shared publications - Zi-Chun Hua
The State Key Laboratory of Pharmaceutical Biotechnology and Department of Neurology of Nanjing Drum Tower Hospital, School of Life Sciences and The Affiliated Hospital of Nanjing University Medical School, Nanjing University, Nanjing 210023, China; Changzhou High-Tech Research Institute of Nanjing University and Jiangsu TargetPharma Laboratories Inc., Changzhou 213164, China; Faculty of Pharmaceutical Sciences, Xinxiang Medical University, Xinxiang 453002, China
5 shared publications Weihua Gong
Department of Surgery of Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310012, China
3 shared publicationsWeixia Sun
3 shared publicationsXiaoxin Zhang
The State Key Laboratory of Pharmaceutical Biotechnology, School of Life Science and School of Stomatology, Affiliated Stomatological Hospital, Nanjing University, Nanjing, 210093, Jiangsu, China
3 shared publicationsXie Li
3 shared publications
Latest Publications
- Open Access
- 2 September 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (9)
TBK1 phosphorylates HDAC3 to promote NDP52 deacetylation and accelerate intracellular bacterial clearance
- 2 September 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (9)
Open AccessTBK1 phosphorylates HDAC3 to promote NDP52 deacetylation and accelerate intracellular bacterial clearance
- Open Access
- 27 June 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Targeting EZH2-driven cholesterol metabolic vulnerability through Napabucasin suppresses ovarian cancer metastasis
Ovarian cancer represents the most lethal gynecologic malignancy, with tumor metastasis being the primary contributor to patient mortality. EZH2, frequently overexpressed in various cancers, has been implicated in promoting metastatic progression through metabolic dysregulation. However, the mechanistic basis by which EZH2 reprograms cholesterol metabolism to facilitate ovarian cancer metastasis remains poorly defined. In this study, we demonstrated that EZH2 is highly expressed in both primary and metastatic ovarian cancer tissues, correlating positively with poor clinical prognosis. Genetic silencing of EZH2 significantly suppressed tumor proliferation and metastatic dissemination. Mechanistically, EZH2 overexpression activated the NF-κB-Rap1A signaling axis and orchestrated cholesterol metabolic reprogramming by activating SREBP2, while repressing TMED10, to promote ovarian cancer metastasis. Furthermore, we identified Napabucasin as a potent suppressor of EZH2/Rap1A axis and cholesterol metabolism. Notably, Napabucasin effectively inhibited ovarian cancer metastasis in vivo. Collectively, our findings elucidate a previously unrecognized mechanism by which EZH2 governs metastatic progression through cholesterol metabolic rewiring and propose Napabucasin as a promising therapeutic strategy for ovarian cancer, particularly in tumors with EZH2 hyperactivation.
- 27 June 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Open AccessTargeting EZH2-driven cholesterol metabolic vulnerability through Napabucasin suppresses ovarian cancer metastasis
Ovarian cancer represents the most lethal gynecologic malignancy, with tumor metastasis being the primary contributor to patient mortality. EZH2, frequently overexpressed in various cancers, has been implicated in promoting metastatic progression through metabolic dysregulation. However, the mechanistic basis by which EZH2 reprograms cholesterol metabolism to facilitate ovarian cancer metastasis remains poorly defined. In this study, we demonstrated that EZH2 is highly expressed in both primary and metastatic ovarian cancer tissues, correlating positively with poor clinical prognosis. Genetic silencing of EZH2 significantly suppressed tumor proliferation and metastatic dissemination. Mechanistically, EZH2 overexpression activated the NF-κB-Rap1A signaling axis and orchestrated cholesterol metabolic reprogramming by activating SREBP2, while repressing TMED10, to promote ovarian cancer metastasis. Furthermore, we identified Napabucasin as a potent suppressor of EZH2/Rap1A axis and cholesterol metabolism. Notably, Napabucasin effectively inhibited ovarian cancer metastasis in vivo. Collectively, our findings elucidate a previously unrecognized mechanism by which EZH2 governs metastatic progression through cholesterol metabolic rewiring and propose Napabucasin as a promising therapeutic strategy for ovarian cancer, particularly in tumors with EZH2 hyperactivation.
- Top Cited PapersOpen Access
- 20 March 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-22
Integrative single-cell metabolomics and phenotypic profiling reveals metabolic heterogeneity of cellular oxidation and senescence
Emerging evidence has unveiled heterogeneity in phenotypic and transcriptional alterations at the single-cell level during oxidative stress and senescence. Despite the pivotal roles of cellular metabolism, a comprehensive elucidation of metabolomic heterogeneity in cells and its connection with cellular oxidative and senescent status remains elusive. By integrating single-cell live imaging with mass spectrometry (SCLIMS), we establish a cross-modality technique capturing both metabolome and oxidative level in individual cells. The SCLIMS demonstrates substantial metabolomic heterogeneity among cells with diverse oxidative levels. Furthermore, the single-cell metabolome predicted heterogeneous states of cells. Remarkably, the pre-existing metabolomic heterogeneity determines the divergent cellular fate upon oxidative insult. Supplementation of key metabolites screened by SCLIMS resulted in a reduction in cellular oxidative levels and an extension of C. elegans lifespan. Altogether, SCLIMS represents a potent tool for integrative metabolomics and phenotypic profiling at the single-cell level, offering innovative approaches to investigate metabolic heterogeneity in cellular processes.
- 20 March 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-22
Top Cited PapersOpen AccessIntegrative single-cell metabolomics and phenotypic profiling reveals metabolic heterogeneity of cellular oxidation and senescence
Emerging evidence has unveiled heterogeneity in phenotypic and transcriptional alterations at the single-cell level during oxidative stress and senescence. Despite the pivotal roles of cellular metabolism, a comprehensive elucidation of metabolomic heterogeneity in cells and its connection with cellular oxidative and senescent status remains elusive. By integrating single-cell live imaging with mass spectrometry (SCLIMS), we establish a cross-modality technique capturing both metabolome and oxidative level in individual cells. The SCLIMS demonstrates substantial metabolomic heterogeneity among cells with diverse oxidative levels. Furthermore, the single-cell metabolome predicted heterogeneous states of cells. Remarkably, the pre-existing metabolomic heterogeneity determines the divergent cellular fate upon oxidative insult. Supplementation of key metabolites screened by SCLIMS resulted in a reduction in cellular oxidative levels and an extension of C. elegans lifespan. Altogether, SCLIMS represents a potent tool for integrative metabolomics and phenotypic profiling at the single-cell level, offering innovative approaches to investigate metabolic heterogeneity in cellular processes.
- Top Cited PapersOpen Access
- 18 August 2023
- Published by Taylor & Francis in Autophagy
- Vol. 19 (12) , 3240-3241
Lactate is a bridge linking glycolysis and autophagy through lactylation
Lactate is a glycolysis product that is produced from pyruvate by LDH (lactate dehydrogenase) and plays an important role in physiological and pathological processes. However, whether lactate regulates autophagy is still unknown. We recently reported that LDHA is phosphorylated at serine 196 by ULK1 (unc-51 like kinase 1) under nutrient-deprivation conditions, promoting lactate production. Then, lactate mediates PIK3C3/VPS34 lactylation at lysine 356 and lysine 781 via acyltransferase KAT5/TIP60. PIK3C3/VPS34 lactylation enhances the association of PIK3C3/VPS34 with BECN1 (beclin 1, autophagy related), ATG14 and UVRAG, increases PIK3C3/VPS34 lipid kinase activity, promotes macroautophagy/autophagy and facilitates the endolysosomal degradation pathway. PIK3C3/VPS34 hyperlactylation induces autophagy and plays an essential role in skeletal muscle homeostasis and cancer progression. Overall, this study describes an autophagy regulation mechanism and the integration of two highly conserved life processes: glycolysis and autophagy.
- 18 August 2023
- Published by Taylor & Francis in Autophagy
- Vol. 19 (12) , 3240-3241
Top Cited PapersOpen AccessLactate is a bridge linking glycolysis and autophagy through lactylation
Lactate is a glycolysis product that is produced from pyruvate by LDH (lactate dehydrogenase) and plays an important role in physiological and pathological processes. However, whether lactate regulates autophagy is still unknown. We recently reported that LDHA is phosphorylated at serine 196 by ULK1 (unc-51 like kinase 1) under nutrient-deprivation conditions, promoting lactate production. Then, lactate mediates PIK3C3/VPS34 lactylation at lysine 356 and lysine 781 via acyltransferase KAT5/TIP60. PIK3C3/VPS34 lactylation enhances the association of PIK3C3/VPS34 with BECN1 (beclin 1, autophagy related), ATG14 and UVRAG, increases PIK3C3/VPS34 lipid kinase activity, promotes macroautophagy/autophagy and facilitates the endolysosomal degradation pathway. PIK3C3/VPS34 hyperlactylation induces autophagy and plays an essential role in skeletal muscle homeostasis and cancer progression. Overall, this study describes an autophagy regulation mechanism and the integration of two highly conserved life processes: glycolysis and autophagy.
- Top Cited PapersOpen Access
- 2 June 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (22) , eadg4993
ULK1-mediated metabolic reprogramming regulates Vps34 lipid kinase activity by its lactylation
Autophagy and glycolysis are highly conserved biological processes involved in both physiological and pathological cellular programs, but the interplay between these processes is poorly understood. Here, we show that the glycolytic enzyme lactate dehydrogenase A (LDHA) is activated upon UNC-51–like kinase 1 (ULK1) activation under nutrient deprivation. Specifically, ULK1 directly interacts with LDHA, phosphorylates serine-196 when nutrients are scarce and promotes lactate production. Lactate connects autophagy and glycolysis through Vps34 lactylation (at lysine-356 and lysine-781), which is mediated by the acyltransferase KAT5/TIP60. Vps34 lactylation enhances the association of Vps34 with Beclin1, Atg14L, and UVRAG, and then increases Vps34 lipid kinase activity. Vps34 lactylation promotes autophagic flux and endolysosomal trafficking. Vps34 lactylation in skeletal muscle during intense exercise maintains muscle cell homeostasis and correlates with cancer progress by inducing cell autophagy. Together, our findings describe autophagy regulation mechanism and then integrate cell autophagy and glycolysis.
- 2 June 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (22) , eadg4993
Top Cited PapersOpen AccessULK1-mediated metabolic reprogramming regulates Vps34 lipid kinase activity by its lactylation
Autophagy and glycolysis are highly conserved biological processes involved in both physiological and pathological cellular programs, but the interplay between these processes is poorly understood. Here, we show that the glycolytic enzyme lactate dehydrogenase A (LDHA) is activated upon UNC-51–like kinase 1 (ULK1) activation under nutrient deprivation. Specifically, ULK1 directly interacts with LDHA, phosphorylates serine-196 when nutrients are scarce and promotes lactate production. Lactate connects autophagy and glycolysis through Vps34 lactylation (at lysine-356 and lysine-781), which is mediated by the acyltransferase KAT5/TIP60. Vps34 lactylation enhances the association of Vps34 with Beclin1, Atg14L, and UVRAG, and then increases Vps34 lipid kinase activity. Vps34 lactylation promotes autophagic flux and endolysosomal trafficking. Vps34 lactylation in skeletal muscle during intense exercise maintains muscle cell homeostasis and correlates with cancer progress by inducing cell autophagy. Together, our findings describe autophagy regulation mechanism and then integrate cell autophagy and glycolysis.
- Open Access
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
ULK1-Mediated Metabolic Reprogramming Regulates Vps34 Lipid Kinase Activity by Its Lactylation
Autophagy and glycolysis are highly conserved biological processes involved in both physiological and pathological cellular programs, but the interplay between these processes is poorly understood. Here, we show that the glycolytic enzyme lactate dehydrogenase A (LDHA) is activated upon UNC-51-like kinase 1 (ULK1) activation under nutrient deprivation. Specifically, ULK1 directly interacts with LDHA, phosphorylates serine 196 when nutrients are scarce and promotes lactate production. Lactate connects autophagy and glycolysis through autophagy core regulator Vps34 lactylation (at lysine 356 and lysine 781), which is mediated by the acyltransferase KAT5/TIP60. Vps34 lactylation enhances the association of Vps34 with Beclin1, Atg14L and UVRAG, increasing Vps34 lipid kinase activity. Vps34 lactylation promotes autophagic flux and endo-lysosomal trafficking. Lactate-mediated Vps34 lactylation in human lung and gastric cancer is significantly increased and is accompanied by high LDHA expression and lactate levels, promoting cancer cell autophagy and facilitating tumor progression. In addition, Vps34 lactylation in skeletal muscle during intense exercise maintains muscle cell homeostasis by inducing muscle cell autophagy. Altogether, this work describes not only a novel autophagy regulation mechanism but also the integration of autophagy and glycolysis, which are both involved in cancer progression and skeletal muscle homeostasis.
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Open AccessULK1-Mediated Metabolic Reprogramming Regulates Vps34 Lipid Kinase Activity by Its Lactylation
Autophagy and glycolysis are highly conserved biological processes involved in both physiological and pathological cellular programs, but the interplay between these processes is poorly understood. Here, we show that the glycolytic enzyme lactate dehydrogenase A (LDHA) is activated upon UNC-51-like kinase 1 (ULK1) activation under nutrient deprivation. Specifically, ULK1 directly interacts with LDHA, phosphorylates serine 196 when nutrients are scarce and promotes lactate production. Lactate connects autophagy and glycolysis through autophagy core regulator Vps34 lactylation (at lysine 356 and lysine 781), which is mediated by the acyltransferase KAT5/TIP60. Vps34 lactylation enhances the association of Vps34 with Beclin1, Atg14L and UVRAG, increasing Vps34 lipid kinase activity. Vps34 lactylation promotes autophagic flux and endo-lysosomal trafficking. Lactate-mediated Vps34 lactylation in human lung and gastric cancer is significantly increased and is accompanied by high LDHA expression and lactate levels, promoting cancer cell autophagy and facilitating tumor progression. In addition, Vps34 lactylation in skeletal muscle during intense exercise maintains muscle cell homeostasis by inducing muscle cell autophagy. Altogether, this work describes not only a novel autophagy regulation mechanism but also the integration of autophagy and glycolysis, which are both involved in cancer progression and skeletal muscle homeostasis.
- Open Access
- 7 May 2021
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 11 (10) , 3165-3177
Salmonella flagella confer anti-tumor immunological effect via activating Flagellin/TLR5 signalling within tumor microenvironment
- 7 May 2021
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 11 (10) , 3165-3177
Open AccessSalmonella flagella confer anti-tumor immunological effect via activating Flagellin/TLR5 signalling within tumor microenvironment
- 12 June 2020
- Published by Annual Reviews in Annual Review of Analytical Chemistry
- Vol. 13 (1) , 293-314
Lighting Up Live-Cell and In Vivo Central Carbon Metabolism with Genetically Encoded Fluorescent Sensors
As the core component of cell metabolism, central carbon metabolism, consisting of glycolysis, the pentose phosphate pathway, and the tricarboxylic acid cycle converts nutrients into metabolic precursors for biomass and energy to sustain the life of virtually all extant species. The metabolite levels or distributions in central carbon metabolism often change dynamically with cell fates, development, and disease progression. However, traditional biochemical methods require cell lysis, making it challenging to obtain spatiotemporal information about metabolites in living cells and in vivo. Genetically encoded fluorescent sensors allow the rapid, sensitive, specific, and real-time readout of metabolite dynamics in living organisms, thereby offering the potential to fill the gap in current techniques. In this review, we introduce recent progress made in the development of genetically encoded fluorescent sensors for central carbon metabolism and discuss their advantages, disadvantages, and applications. Moreover, several future directions of metabolite sensors are also proposed.
- 12 June 2020
- Published by Annual Reviews in Annual Review of Analytical Chemistry
- Vol. 13 (1) , 293-314
Lighting Up Live-Cell and In Vivo Central Carbon Metabolism with Genetically Encoded Fluorescent Sensors
As the core component of cell metabolism, central carbon metabolism, consisting of glycolysis, the pentose phosphate pathway, and the tricarboxylic acid cycle converts nutrients into metabolic precursors for biomass and energy to sustain the life of virtually all extant species. The metabolite levels or distributions in central carbon metabolism often change dynamically with cell fates, development, and disease progression. However, traditional biochemical methods require cell lysis, making it challenging to obtain spatiotemporal information about metabolites in living cells and in vivo. Genetically encoded fluorescent sensors allow the rapid, sensitive, specific, and real-time readout of metabolite dynamics in living organisms, thereby offering the potential to fill the gap in current techniques. In this review, we introduce recent progress made in the development of genetically encoded fluorescent sensors for central carbon metabolism and discuss their advantages, disadvantages, and applications. Moreover, several future directions of metabolite sensors are also proposed.
- 25 October 2019
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 366 (6464) , 460-467
Palmitoylation of NOD1 and NOD2 is required for bacterial sensing
NODs require S-palmitoylation to signal: The compartmentalization of proteins within the cell is essential for their function. The addition of lipid molecules redistributes proteins to the cell surface or to membrane-bound organelles. Working in transgenic mice and in tissue cultured cells, Lu et al. found that nucleotide oligomerization domain–like receptors 1 and 2 (NOD1 and NOD2), two proteins responsible for detecting bacterial products, required lipid modifications for their recruitment to the cell membrane and function. The specific modification, palmitoylation at a cysteine thiol, was mediated by the enzyme ZDHHC5. Loss of ZDHHC5 or removal of key modification residues in NOD1 and NOD2 abolished their function, compromising antibacterial responses. Human variants of NOD2 display altered palmitoylation, which could help to explain many inflammatory conditions, such as irritable bowel syndrome. Science , this issue p. 460
- 25 October 2019
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 366 (6464) , 460-467
Palmitoylation of NOD1 and NOD2 is required for bacterial sensing
NODs require S-palmitoylation to signal: The compartmentalization of proteins within the cell is essential for their function. The addition of lipid molecules redistributes proteins to the cell surface or to membrane-bound organelles. Working in transgenic mice and in tissue cultured cells, Lu et al. found that nucleotide oligomerization domain–like receptors 1 and 2 (NOD1 and NOD2), two proteins responsible for detecting bacterial products, required lipid modifications for their recruitment to the cell membrane and function. The specific modification, palmitoylation at a cysteine thiol, was mediated by the enzyme ZDHHC5. Loss of ZDHHC5 or removal of key modification residues in NOD1 and NOD2 abolished their function, compromising antibacterial responses. Human variants of NOD2 display altered palmitoylation, which could help to explain many inflammatory conditions, such as irritable bowel syndrome. Science , this issue p. 460
- 27 March 2019
- Published by Taylor & Francis in Autophagy
- Vol. 15 (6) , 1120-1121
RUBCNL/Pacer and RUBCN/Rubicon in regulation of autolysosome formation and lipid metabolism
Recently, we identified a vertebrate-specific macroautophagy/autophagy regulator, RUBCNL/Pacer, which promotes autolysosome formation by engaging the class III phosphatidylinositol 3-kinase (PtdIns3K) and HOPS complexes. Hepatocyte-specific rubcnl knockout in mice results in impaired autophagy flux, glycogen and lipid accumulation, and liver fibrosis. We further showed that under nutrient-rich conditions RUBCNL is inactivated by MTORC1-mediated phosphorylation. When nutrients are insufficient, RUBCNL is dephosphorylated, which facilitates its acetylation by the activated GSK3-KAT5/TIP60 pathway. RUBCNL acetylation significantly enhances HOPS complex recruitment, which eventually results in more efficient autophagosome maturation and lipid metabolism both in vitro and in vivo. Therefore, our work not only demonstrates that RUBCNL is essential for hepatic autophagy and liver homeostasis, but also reveals a signal integration mechanism involved in late stages of autophagy and lipid metabolism. Interestingly, these in vitro and in vivo functional data on RUBCNL are partially the opposite of the results from RUBCN/Rubicon studies that were either obtained by us or others. This implies a dual molecular switch model that is controlled by RUBCNL and RUBCN in modulation of autophagosome maturation and lipid metabolism.
- 27 March 2019
- Published by Taylor & Francis in Autophagy
- Vol. 15 (6) , 1120-1121
RUBCNL/Pacer and RUBCN/Rubicon in regulation of autolysosome formation and lipid metabolism
Recently, we identified a vertebrate-specific macroautophagy/autophagy regulator, RUBCNL/Pacer, which promotes autolysosome formation by engaging the class III phosphatidylinositol 3-kinase (PtdIns3K) and HOPS complexes. Hepatocyte-specific rubcnl knockout in mice results in impaired autophagy flux, glycogen and lipid accumulation, and liver fibrosis. We further showed that under nutrient-rich conditions RUBCNL is inactivated by MTORC1-mediated phosphorylation. When nutrients are insufficient, RUBCNL is dephosphorylated, which facilitates its acetylation by the activated GSK3-KAT5/TIP60 pathway. RUBCNL acetylation significantly enhances HOPS complex recruitment, which eventually results in more efficient autophagosome maturation and lipid metabolism both in vitro and in vivo. Therefore, our work not only demonstrates that RUBCNL is essential for hepatic autophagy and liver homeostasis, but also reveals a signal integration mechanism involved in late stages of autophagy and lipid metabolism. Interestingly, these in vitro and in vivo functional data on RUBCNL are partially the opposite of the results from RUBCN/Rubicon studies that were either obtained by us or others. This implies a dual molecular switch model that is controlled by RUBCNL and RUBCN in modulation of autophagosome maturation and lipid metabolism.